pharmacogenomics
(4)
The Genome That Keeps Giving
MyOme wants a single DNA sample to keep answering new medical questions. Its bet is that the useful part of sequencing is not the first report, but what a clinician can ask of it years later.
The Minneapolis Shop That Turns Lab IP Into Real Companies
Most venture firms write checks and wait. Invenshure hires the scientists, licenses the patents, and builds the company itself - one hard problem at a time.
Cipherome, Inc.
Cipherome is a San Jose-based clinical genomics and bioinformatics company on a mission to find the drug that works for each individual. Its no-code platform COMPASS lets researchers transform, query, and analyze massive clinical and genomic datasets - like the 500,000-participant UK Biobank - without writing code, while its Xentinel platform uses explainable AI to predict and reduce adverse drug reactions. Backed by roughly $16-23M through a Series B, the 12-person team pairs Silicon Valley software with Seoul National University biomedical-informatics research.
Helix
Helix is a San Mateo-based population genomics company that helps health systems, life sciences companies, and public health organizations weave genomic data into everyday patient care. Built around its proprietary Exome+ assay and the first FDA-authorized whole exome sequencing platform, Helix powers large-scale precision health programs at partners like Mayo Clinic and Renown Health, with a research network spanning hundreds of thousands of sequenced participants.